Vishwakarma University, Pune | Impactful Research Projects

Name of the Faculty :	Dr. Om Bagade
Designation :	Associate Professor
E-mail :	om.bagade@vupune.ac.in
Faculty :	Pharmacy
Department :	Pharmacy
LinkedIn :	https://www.linkedin.com/in/dr-om-mahadeo-bagade-615116157/?otpToken=MTQwNjFlZTMxMDJkY2RjMGI1MjQwNGV
Google Scholar URL :	https://scholar.google.co.in/citations?hl=en&user=eTQ2z9EAAAAJ&view_op=list_works&authuser=2
ResearchGate :	https://www.researchgate.net/profile/Om-Bagade
ORCID ID :	0000-0002-5398-2752
Research Area :	Particle Engineering, Nanotechnology, Solubility Enhancement, Novel Drug Delivery system and Quality by Design

Research Summary :

Dr. Om M. Bagade- A dynamic academician, researcher, and professional in the pharmacy field. He is a university rank holder at the UG and PG levels. He has also completed a Diploma in Intellectual Property Law from Symbiosis International University, Pune. He earned his Ph.D. from Savitribai Phule Pune University (SPPU), Maharashtra, India. Currently, he is working as an Associate Professor in Pharmaceutics Department, at Vishwakarma University, Pune, India. He has been shortlisted for an interview for the Drug Inspector post (MPSC). During his cram he has manifold scholarships and rewards for his glory like McKinney (Texas), USA, FFE Philippines, White Gold Moderate award, AICTE (GATE), Sir Ratan Tata, Sir Dorabaji Tata, Mahindra and Mahindra, and Sir Jindal scholarships etc. He has around 15 years of total experience in teaching and guided more than 10 PG students. He has published more than 60 research and review articles in renowned international journals of repute with good impact factors and more than 70 research presentations at various conferences and grabbed the best research paper awards in many events. Furthermore, he has published around 06 Books, 12 Patents, and 16 Book Chapters at the National and International level of standard. Moreover, one of his research projects in pharmaceutics has been funded by BCUD, SPPU.

[Best viewed in IE 10+, Firefox, Chrome, Safari, Opera.]